vendredi 4 décembre 2015

Onco Actu du 4 décembre 2015

1. Biologie

‘Master switch’ helps cancer cells survive stress [The Institute of Cancer Research]

Spreading cancer cells must change their environment to grow [Cancer Research UK]

5. Traitements

"Chemobrain" studied by researchers at Stanford, MD Anderson [Scope Blog]

5.12 Immunothérapies

bluebird bio, ViroMed Team Up to Develop CAR T Cell Therapies [GEN]

5.2.1 Pharma - Partenariats

Boehringer Ingelheim and MD Anderson Cancer Center join forces to discover new treatment approaches for pancreatic cancer [Boehringer Ingelheim]

5.2.3 Pharma - économie

Avalon, TPG Lead $15M Deal to Advance Metformin as Cancer Drug [Xconomy]

Can Lightning Strike Three Times? Prostate Cancer Drug Developer Gets $53M To Find Out - Forbes

5.4 Traitements - Economie

A Radical Proposal For Bringing Down The Cost Of Cancer Drugs [Forbes]

NICE u-turn on Novartis' multiple myeloma drug [PharmaTimes]

UK pays among 'lowest prices' for cancer drugs [BBC News]

6.1 Observation

Depressed head and neck cancer patients three-and-one-half times less likely to survive, have higher recurrence risk [MD Anderson Cancer Center]

6.11 Patients

Well: Living With Cancer: Hurry Up and Wait [NY Times]

6.2 Implants mammaires

Breast Implants Undergo Reconstruction [NY Times]

6.6 Publications

Research Councils’ grants system to capture ORCID iDs from early next year [Research Councils UK]

6.7.2 Applis

MD Anderson Kicks Off Apple Watch Pilot for Breast Cancer Patients [HIT Consultant]